Federal Register / Vol. 79, No. 2 / Friday, January 3, 2014 / Notices 397 

table below account for about half of the 

total participants in the CWHSP. 

• Pathologist Invoice—42 CFR 37.202 

specifies procedures for the NCWAS. 

The invoice submitted by the 

pathologist must contain a statement 

that the pathologist is not receiving any 

other compensation for the autopsy. 

Each participating pathologist may use 

their individual invoice as long as this 

statement is added. It is estimated that 

only 5 minutes is required for the 

pathologist to add this statement to the 

standard invoice that they routinely use. 

• Pathologist Report—42 CFR 37.203 

provides the autopsy specifications. The 

pathologist must submit information 

found at autopsy, slides, blocks of 

tissue, and a final diagnosis indicating 

presence or absence of pneumoconiosis. 

The format of the autopsy reports are 

variable depending on the pathologist 

conducting the autopsy. Since an 

autopsy report is routinely completed 

by a pathologist, the only additional 

burden is the specific request for a 

clinical abstract of terminal illness and 

final diagnosis relating to 

pneumoconiosis. Therefore, only 5 

minutes of additional burden is 

estimated for the pathologist’s report. 

• Consent, Release and History Form 

(2.6)—This form documents written 

authorization from the next-of-kin to 

perform an autopsy on the deceased 

miner. A minimum of essential 

information is collected regarding the 

deceased miner including the 

occupational history and smoking 

history. From past experience, it is 

estimated that 15 minutes is required for 

the next-of-kin to complete this form. 

There are no costs to respondents 

other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden/ 

response 

(in hrs) 

Total burden 

(in hrs) 

Coal Mine Operators ......................... Form 2.10 ......................................... 200 1 30/60 100 

X-ray Facility Supervisor ................... Form 2.11 ......................................... 100 1 30/60 50 

X-ray—Coal Miners ........................... No form required .............................. 5,000 1 15/60 1,250 

Coal Miners ....................................... Form 2.9 ........................................... 5,000 1 20/60 1,667 

B Reader Physicians ........................ Form 2.8 ........................................... 10,000 1 3/60 500 

Physicians taking the B Reader Examination.Form 2.12 ......................................... 100 1 10/60 17 

Spirometry Test—Coal Miners .......... No form required .............................. 2,500 1 20/60 833 

Pathologist ........................................ Invoice—No standard form .............. 5 1 5/60 1 

Pathologist ........................................ Pathology Report—No standard 

form.

5 1 5/60 1 

Next-of-kin for deceased miner ........ Form 2.6 ........................................... 5 1 15/60 1 

Total ........................................... ........................................................... ........................ ........................ ........................ 4,420 

Leroy Richardson, 

Chief, Information Collection Review Office, 

Office of Scientific Integrity, Office of the 

Associate Director for Science, Office of the 

Director, Centers for Disease Control and 

Prevention. 

[FR Doc. 2013–31464 Filed 1–2–14; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

Statement of Organization, Functions, 

and Delegations of Authority 

Part F of the Statement of 

Organization, Functions, and 

Delegations of Authority for the 

Department of Health and Human 

Services, Centers for Medicare & 

Medicaid Services (CMS), (last amended 

at Federal Register, Vol. 76, No. 75, pp. 

21908–21909, dated April 19, 2011, and 

Vol. 77, No. 140, p. 42740, dated July 

20, 2012) is amended to reflect the 

abolishment of the Office of Public 

Engagement (OPE). The Offices of 

Hearings and Inquiries (OHI) was 

established and reports directly to the 

Chief Operating Officer (COO). 

CMS modified its structure to: (1) 

Conduct Marketplace eligibility appeals; 

(2) assist Medicare beneficiaries with 

complaints, inquiries, and grievances, 

and to gather the information necessary 

to file Medicare appeals; and (3) 

conduct administrative hearings for 

institutional appeals which fall under 

the jurisdiction of the Provider 

Reimbursement Review Board, the 

Medicare Geographic Classification 

Review Board, and the CMS Hearings 

Officers. 

The functions in OPE include the 

Medicare Ombudsman, tribal affairs, 

and emergency preparedness and 

continuity of operations. The Medicare 

Ombudsman was moved to OHI, tribal 

affairs was moved to the Center for 

Medicaid and CHIP Services (CMCS), 

and emergency preparedness and 

continuity of operations was moved to 

the Consortium for Quality 

Improvement and Survey & Certification 

Operations (CQISCO). In addition, the 

Office of Marketplace Eligibility 

Appeals was established in OHI, and the 

Office of Hearings was moved from the 

Office of Operations Management 

(OOM) to OHI. 

Part F., Section FC. 10 (Organization) 

is revised as follows: 

Office of the Administrator (FC) 

Office of Equal Opportunity and Civil 

Rights (FCA) 

Office of Legislation (FCC) 

Office of the Actuary (FCE) 

Office of Strategic Operations and 

Regulatory Affairs (FCF) 

Center for Clinical Standards and 

Quality (FCG) 

Center for Medicare (FCH) 

Center for Medicaid and CHIP Services 

(FCJ) 

Center for Strategic Planning (FCK) 

Center for Program Integrity (FCL) 

Chief Operating Officer (FCM) 

Office of Minority Health (FCN) 

Center for Medicare and Medicaid 

Innovation (FCP) 

Federal Coordinated Health Care Office 

(FCQ) 

Center for Consumer Information and 

Insurance Oversight (FCR) 

Office of Communications (FCT) 

Delegations of Authority 

All delegations and re-delegations of 

authority made to officials and 

employees of affected organizational 

mstockstill on DSK4VPTVN1PROD with NOTICES

398 Federal Register / Vol. 79, No. 2 / Friday, January 3, 2014 / Notices 

components will continue in them or 

their successor organization pending 

further re-delegation, provided they are 

consistent with the movement of 

functions. 

Authority: 44 U.S.C. 3101. 

Dated: December 24, 2013. 

Marilyn Tavenner, 

Administrator, Centers for Medicare & 

Medicaid Services. 

[FR Doc. 2013–31206 Filed 1–2–14; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2013–N–0001] 

Risk Communications Advisory 

Committee; Notice of Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

This notice announces a forthcoming 

meeting of a public advisory committee 

of the Food and Drug Administration 

(FDA). The meeting will be open to the 

public. 

Name of Committee: Risk 

Communications Advisory Committee. 

General Function of the Committee: 

To provide advice and 

recommendations to the Agency on 

FDA’s regulatory issues. 

Date and Time: The meeting will be 

held on February 3 and 4, 2014, from 9 

a.m. to 5 p.m. 

Location: FDA White Oak Campus, 

10903 New Hampshire Ave., Bldg. 31 

Conference Center, the Great Room (Rm. 

1503), Silver Spring, MD 20993–0002. 

Information regarding special 

accommodations due to a disability, 

visitor parking, and transportation may 

be accessed at: http://www.fda.gov/

AdvisoryCommittees/default.htm; under 

the heading ‘‘Resources for You,’’ click 

on ‘‘Public Meetings at the FDA White 

Oak Campus.’’ Please note that visitors 

to the White Oak Campus must enter 

through Building 1. 

Contact Person: Luis G. Bravo, Food 

and Drug Administration, 10903 New 

Hampshire Ave., Bldg. 32, Rm. 3274, 

Silver Spring, MD 20993–0002, 240– 

402–5274, or FDA Advisory Committee 

Information Line, 1–800–741–8138 

(301–443–0572 in the Washington, DC 

area). A notice in the Federal Register 

about last minute modifications that 

impact a previously announced 

advisory committee meeting cannot 

always be published quickly enough to 

provide timely notice. Therefore, you 

should always check the Agency’s Web 

site at http://www.fda.gov/Advisory

Committees/default.htm and scroll 

down to the appropriate advisory 

committee meeting link, or call the 

advisory committee information line to 

learn about possible modifications 

before coming to the meeting. 

If you are unable to join us in person, 

we encourage you to watch the Webcast. 

Visit the Risk Communication Advisory 

Committee Web site at http://

www.fda.gov/AdvisoryCommittees/

CommitteesMeetingMaterials/Risk

CommunicationAdvisoryCommittee/

default.htm. The link will become 

active shortly before the open session 

begins at 9 a.m. 

Agenda: On February 3 and 4, 2014, 

the committee will meet to discuss 

methods for identifying the impact and 

increasing the reach of communications 

on topics of interest to consumers. The 

discussion will also address how FDA 

can evaluate whether its ‘‘Consumer 

Updates’’ (http://www.fda.gov/For

Consumers/ConsumerUpdates/

default.htm) are reaching the targeted 

population, and whether they are 

increasing awareness and understanding 

of the key risk messages. The discussion 

will also assess whether the 

communications are having the 

intended impact on knowledge, 

behaviors, or outcomes. 

FDA intends to make background 

material available to the public no later 

than 2 business days before the meeting. 

If FDA is unable to post the background 

material on its Web site prior to the 

meeting, the background material will 

be made publicly available at the 

location of the advisory committee 

meeting, and the background material 

will be posted on FDA’s Web site after 

the meeting. Background material is 

available at http://www.fda.gov/

AdvisoryCommittees/Calendar/

default.htm. Scroll down to the 

appropriate advisory committee meeting 

link. 

Procedure: Interested persons may 

present data, information, or views, 

orally or in writing, on issues pending 

before the committee. Written 

submissions may be made to the contact 

person on or before January 27, 2014. 

Oral presentations from the public will 

be scheduled between approximately 1 

p.m. and 2 p.m. Those individuals 

interested in making formal oral 

presentations should notify the contact 

person and submit a brief statement of 

the general nature of the evidence or 

arguments they wish to present, the 

names and addresses of proposed 

participants, and an indication of the 

approximate time requested to make 

their presentation on or before January 

17, 2014. Time allotted for each 

presentation may be limited. If the 

number of registrants requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

open public hearing session, FDA may 

conduct a lottery to determine the 

speakers for the scheduled open public 

hearing session. The contact person will 

notify interested persons regarding their 

request to speak by January 21, 2014. 

Persons attending FDA’s advisory 

committee meetings are advised that the 

Agency is not responsible for providing 

access to electrical outlets. 

FDA welcomes the attendance of the 

public at its advisory committee 

meetings and will make every effort to 

accommodate persons with physical 

disabilities or special needs. If you 

require special accommodations due to 

a disability, please contact Luis G. Bravo 

at least 7 days in advance of the 

meeting. 

FDA is committed to the orderly 

conduct of its advisory committee 

meetings. Please visit our Web site at 

http://www.fda.gov/Advisory

Committees/AboutAdvisoryCommittees/

ucm111462.htm for procedures on 

public conduct during advisory 

committee meetings. 

Notice of this meeting is given under 

the Federal Advisory Committee Act (5 

U.S.C. app. 2). 

Dated: December 30, 2013. 

Jill Hartzler Warner, 

Acting Associate Commissioner for Special 

Medical Programs. 

[FR Doc. 2013–31486 Filed 1–2–14; 8:45 am] 

BILLING CODE 4160–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Agency Information Collection 

Activities: Proposed Collection: Public 

Comment Request 

AGENCY: Health Resources and Services 

Administration, HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement for opportunity for public 

comment on proposed data collection 

projects (Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995), the 

Health Resources and Services 

Administration (HRSA) announces 

plans to submit an Information 

Collection Request (ICR), described 

below, to the Office of Management and 

Budget (OMB). Prior to submitting the 

ICR to OMB, HRSA seeks comments 

mstockstill on DSK4VPTVN1PROD with NOTICES